In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Middle age men with short sleep duration have two times higher risk of cardiovascular events than those with normal sleep duration, a cohort study with 21 years follow-up

Session Best Posters 3

Speaker Moa Bengtsson

Congress : ESC Congress 2018

  • Topic : preventive cardiology
  • Sub-topic : Sleep Disorders
  • Session type : Best Posters
  • FP Number : P2465

Authors : M Bengtsson (Gothenburg,SE), P-O Hansson (Gothenburg,SE), C Ergatoudes (Gothenburg,SE), Z Mandalenakis (Gothenburg,SE), D Morales (Gothenburg,SE), A Rosengren (Gothenburg,SE), M Fu (Gothenburg,SE), E Thunstrom (Gothenburg,SE)

M. Bengtsson1 , P.-O. Hansson1 , C. Ergatoudes1 , Z. Mandalenakis1 , D. Morales1 , A. Rosengren1 , M. Fu1 , E. Thunstrom1 , 1University of Gothenburg, Department of Molecular and Clinical Medicine - Gothenburg - Sweden ,

European Heart Journal ( 2018 ) 39 ( Supplement ), 474

Background: Self-assessed short sleep duration have previously been reported to be associated with increased risk of cardiovascular disease. However, other studies do not support this finding.

Purpose: To investigate whether short sleep duration at fifty years of age is associated with increased risk of major adverse cardiovascular events (MACE) during a 21-year follow-up period.

Methods: In 1993 50% (n=1463) of all men living in Gothenburg, born in 1943, were invited to participate. Of those 798 (54%) accepted and filled out questionnaires (including questions about average duration of sleep per day), underwent physical examination, ECG and blood pressure monitoring and anthropometric data were measured. Re-examinations were conducted in 2003 and in 2014. MACE was assessed by a combination of review of medical records of all participants, the Swedish Hospital Discharge registry and the Swedish Death Cause registry. MACE were defined as: acute coronary syndrome, stroke, TIA or heart failure.

Results: Nineteen subjects were excluded because of inadequate sleep questionnaires, and 19 were excluded since they had MACE before baseline. Thus, 760 individuals were included in the final analysis, in total 14,848 person-years at risk. Men with short sleep time had more hypertension and more diabetes, were more obese, were to a larger extent smokers/former smokers, were less physically active and had worse sleep quality. Kaplan-Meier analyses showed an increased risk of MACE in those with sleep less than five hours per night compared to the group set as reference (7–8 hours), p=0.003. Patients with a sleep time of <5 hours had an almost two time higher risk of developing MACE during the follow-up period. The risk increase remained almost the same after adjustment for confounders (Table 2). If, in addition to those with MACE, all those with hypertension at baseline also were excluded, the hazard ratio (HR) for developing MACE remained significant with HR 2.45 (95% confidence interval [CI]1.34 - 4.46) in univariate and HR; 2.39 (95% CI 1.31 - 4.35) in multivariate analysis.

Conclusion: Sleep duration of five hours or less per night in those middle-aged men was associated with a two-fold higher risk of developing cardiovascular disease 2 decades beyond.

Table 2. COX regression
≤5 hours6 hours7–8 hours>8 hours
HR (95% CI)HR (95% CI)referenceHR (95% CI)
Model 1*2.15 (1.28–3.61)0.89 (0.62–1.29)10.75 (0.28–2.04)
Model 21.97 (1.17–3.31)0.89 (0.62–1.29)10.77 (0.29–2.09)
Model 31.93 (1.15–3.25)0.88 (0.61–1.27)10.79 (0.29–2.14)
*Unadjusted. Adjusting for BMI >30, diabetes. Adjusting for BMI >30, diabetes, smoking status.
Figure 1. Kaplan-Meier survival curve

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are